Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04755699 · ClinicalTrials.gov registry record · Early Phase 1

Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis

A Early Phase 1 study of Stroke and Healthy Volunteers, sponsored by Northwell Health.

Recruiting
Registry status
Early Phase 1
Development phase
64
Enrollment target
1
Study location

NCT04755699 is a Early Phase 1 study of Stroke and Healthy Volunteers that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 64 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04755699, a Early Phase 1 study of Stroke and Healthy Volunteers, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
Early Phase 1
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

This is an early feasibility trial to determine whether transcutaneous neuromuscular electrical stimulation, with or without transcutaneous spinal cord stimulation, using an investigational neurostimulation device improves functional arm/hand movements in individuals with paralysis or paresis due to a spinal cord injury or stroke and improves functional arm/hand or leg/foot movements in individuals with paralysis or paresis due to other brain or nerve injuries. In this study, eligible individuals that agree to participate will be asked to attend up to 5 study sessions a week for 1 year (depending on participant availability), with each session lasting up to 4 hours. At the first study session, participants will have their demographic information collected, vital signs assessed, and have measurements performed of their limbs and torso, as appropriate. They will also undergo clinical evaluations and tests to assess their current functional movement and sensation capabilities. During subsequent study sessions, participants will undergo many tasks designed to improve functional movements in paralyzed limbs. Specifically, participants will receive neuromuscular electrical stimulation to the limb(s) and/or electrical stimulation to the spinal cord to evoke specified movements. The stimulation parameters and locations on the spinal column and/or limb(s) that evoke specific movements will be noted. The movements will be assessed with visual inspection, electromyography, and/or sensors. The clinical evaluations and tests to assess functional movement and sensation capabilities will be repeated throughout the study and at the last study session to assess for functional improvements compared to the first study session. Upon completion of these study sessions, the individual's participation in the study is considered complete.

Interventions

  • DEVICE Transcutaneous Electrical Stimulation

Study Locations (1)

New York

  • Northwell Health's The Feinstein Institute for Medical Research - Manhasset

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2020-12-02
Est. Completion 2028-06-30
Phase Early Phase 1

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT04755699

The ClinicalTrials.gov registry entry for NCT04755699 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Electrical Stimulation is the first listed.

NCT04755699 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04755699 about?

NCT04755699 is a clinical study titled "Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis". This is an early feasibility trial to determine whether transcutaneous neuromuscular electrical stimulation, with or without transcutaneous spinal cord stimulation, using an investigational neurostimulation device improves functional arm/hand movements in individuals with paralysis or paresis due to...

What is the current status of trial NCT04755699?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2020-12-02. Estimated completion is 2028-06-30.

What conditions does trial NCT04755699 study?

This clinical trial studies the following conditions: Stroke, Healthy Volunteers, Spinal Cord Injury, Paralysis, Neurological Injury.

What interventions are being tested in trial NCT04755699?

The interventions under investigation include: Transcutaneous Electrical Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04755699?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04755699 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.